China Resources Pharmaceutical Group Ltd (3320) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

China Resources Pharmaceutical Group Ltd (CR Pharma), a subsidiary of China Resources (Holdings) Co Ltd is a pharmaceutical company that offers nutritional supplements. The company offers research and development, manufacture, and distribution of whole drug products. Its products comprise chemical medicines, TCMs, biologics, and health food and traditional Chinese medicine, and nutritional products. CR Pharma offers products in forms of oral solid dosage, large infusion bags, powder vials, oral liquid dosage, injections, and topical preparations. The company markets its products through logistics, wholesale, retail and supply chain services in different provinces across China. CR Pharma is headquartered in Hong Kong.

China Resources Pharmaceutical Group Ltd (3320) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 5
List of Figures 5
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
China Resources Pharmaceutical Group Ltd, Medical Devices Deals, 2012 to YTD 2018 11
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deal Details 15
Partnerships 15
China Resources Pharmaceutical Enters into Agreement with Fujifilm 15
China Resources Pharmaceutical Enters into Co-Development Agreement with WuXi AppTec 16
Pfizer and CR Saike Pharma Enter into Distribution Agreement 17
China Resources Zizhu Enters into Agreement with Uni-Bio Science 18
China Resources Zizhu Pharma Enters into Distribution Agreement with Uni-Bio Science 19
China Resources Pharma and National Center for Nanoscience and Technology Enter into Agreement 20
China Resources Sanjiu Medical To Form Joint Venture 21
Lantheus Medical Imaging Enters Into Co-Marketing Agreement With Beijing Double-Crane Pharma For Ultrasound Contrast Agent 22
Licensing Agreements 23
China Resources Pharma Enters into Licensing Agreement with Xbrane Biopharma 23
China Resources Pharma to Enter into Licensing Agreement with Xbrane Biopharma 24
Basilea Pharma Enters into Licensing Agreement with Shenzhen Gosun Pharma 25
Equity Offering 26
China Resources Pharma Raises USD1.8 Million in IPO 26
Debt Offering 28
China Resources Double Crane Pharma to Raise USD217.8 Million in Public Offering of Bonds 28
Acquisition 29
China Resources Double-Crane Pharma Acquires Hainan Zhonghua Union Pharma 29
China Resources Pharma Acquires 20% Stake in Hefei Tianmai Biotechnology 30
China Resources Sanjiu Medical Acquires Kunming Shenghuo Pharmaceutical 31
China Resources Sanjiu Medical Acquires China Shenghuo Pharma for USD282 Million 32
China Resources Double-Crane Pharma to Acquire 60% Stake in Jinan-based Pharmaceutical Company 33
China Resources Double Crane Pharma Acquires China Resources Saike Pharma for USD578.6 Million 34
The Special Committee Of China Shenghuo Pharma Approves Going Private Proposal From Lans Intl Medicine Investment 35
China Resources Sanjiu Medical Acquires 97.18% Stake In Guilin Tianhe Pharma For US$94 Million 36
Beijing Pharma Rumored To Acquire 42% Stake In Beijing Zizhu Pharma For US$245 Million 37
Beijing Industrial Development And Beijing Zizhu To Sell 24% Stake In China Pharma For US$2 Million 38
China Resources Sanjiu Medical To Acquire Guangdong Shunfeng Pharma For US$95 Million 39
China Resources Pharmaceutical Group Ltd - Key Competitors 40
China Resources Pharmaceutical Group Ltd - Key Employees 41
China Resources Pharmaceutical Group Ltd - Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Recent Developments 44
Financial Announcements 44
Mar 21, 2018: China Resources Pharmaceutical Group: Annual Results Announcement For The Year Ended 31 December 2017 44
Aug 24, 2017: China Resources Pharmaceutical Group: Interim Results Announcement For The Six Months Ended 30 June 2017 53
Corporate Communications 57
May 21, 2018: China Resources Pharmaceutical: Change Of Non-Executive Directors And Member Of The Audit Committee 57
Aug 07, 2017: China Resources Pharmaceutical: Appointment of Independent Non-executive Director 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59

List Of Tables


China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
China Resources Pharmaceutical Group Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
China Resources Pharmaceutical Group Ltd, Medical Devices Deals, 2012 to YTD 2018 11
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
China Resources Pharmaceutical Enters into Agreement with Fujifilm 15
China Resources Pharmaceutical Enters into Co-Development Agreement with WuXi AppTec 16
Pfizer and CR Saike Pharma Enter into Distribution Agreement 17
China Resources Zizhu Enters into Agreement with Uni-Bio Science 18
China Resources Zizhu Pharma Enters into Distribution Agreement with Uni-Bio Science 19
China Resources Pharma and National Center for Nanoscience and Technology Enter into Agreement 20
China Resources Sanjiu Medical To Form Joint Venture 21
Lantheus Medical Imaging Enters Into Co-Marketing Agreement With Beijing Double-Crane Pharma For Ultrasound Contrast Agent 22
China Resources Pharma Enters into Licensing Agreement with Xbrane Biopharma 23
China Resources Pharma to Enter into Licensing Agreement with Xbrane Biopharma 24
Basilea Pharma Enters into Licensing Agreement with Shenzhen Gosun Pharma 25
China Resources Pharma Raises USD1.8 Million in IPO 26
China Resources Double Crane Pharma to Raise USD217.8 Million in Public Offering of Bonds 28
China Resources Double-Crane Pharma Acquires Hainan Zhonghua Union Pharma 29
China Resources Pharma Acquires 20% Stake in Hefei Tianmai Biotechnology 30
China Resources Sanjiu Medical Acquires Kunming Shenghuo Pharmaceutical 31
China Resources Sanjiu Medical Acquires China Shenghuo Pharma for USD282 Million 32
China Resources Double-Crane Pharma to Acquire 60% Stake in Jinan-based Pharmaceutical Company 33
China Resources Double Crane Pharma Acquires China Resources Saike Pharma for USD578.6 Million 34
The Special Committee Of China Shenghuo Pharma Approves Going Private Proposal From Lans Intl Medicine Investment 35
China Resources Sanjiu Medical Acquires 97.18% Stake In Guilin Tianhe Pharma For US$94 Million 36
Beijing Pharma Rumored To Acquire 42% Stake In Beijing Zizhu Pharma For US$245 Million 37
Beijing Industrial Development And Beijing Zizhu To Sell 24% Stake In China Pharma For US$2 Million 38
China Resources Sanjiu Medical To Acquire Guangdong Shunfeng Pharma For US$95 Million 39
China Resources Pharmaceutical Group Ltd, Key Competitors 40
China Resources Pharmaceutical Group Ltd, Key Employees 41
China Resources Pharmaceutical Group Ltd, Other Locations 42
China Resources Pharmaceutical Group Ltd, Subsidiaries 42

List Of Figures


China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
China Resources Pharmaceutical Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
China Resources Pharmaceutical Group Ltd, Medical Devices Deals, 2012 to YTD 2018 11

China Resources Beer (Holdings) Co Ltd - Strategy, SWOT and Corporate Finance Report

China Resources Beer (Holdings) Co Ltd - Strategy, SWOT and Corporate Finance Report market research report available in single user pdf license with Aarkstore Enterprise at USD 175

USD 175 View Report

China Longyuan Power Group Corp Ltd (916) - Financial and Strategic SWOT Analysis Review

China Longyuan Power Group Corp Ltd (916) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has

USD 125 View Report

China Resources Beer (Holdings) Co Ltd - Strategy, SWOT and Corporate Finance Report

China Resources Beer (Holdings) Co Ltd - Strategy, SWOT and Corporate Finance Report market research report available in single user pdf license with Aarkstore Enterprise at USD 175

USD 175 View Report

China Resources Land Ltd - Strategy, SWOT and Corporate Finance Report

China Resources Land Ltd - Strategy, SWOT and Corporate Finance ReportChina Resources Land Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information.

USD 175 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available